Plain-English translation of NCT07219173 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can help adults whose asthma doesn't respond well to their current controller medications. Researchers want to compare how well works compared to placebo (a dummy injection with no active medicine) and to make sure it's safe. The medication is given as an injection under the skin.
Many people with moderate-to-severe asthma continue to have asthma attacks and poor control even when taking standard medications. This trial aims to find out whether this new treatment can help patients who aren't getting adequate relief from existing therapies.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic multiple times over approximately 65 weeks (about 15 months), including screening, treatment, and follow-up visits. During the study, you would receive injections of either the new medication or a placebo under your skin at regular intervals. You would also complete questionnaires about your asthma symptoms and be monitored for any side effects or changes in how well your asthma is controlled.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States